Common Comorbidities Associated With Recurrent C Difficile Infections

The panelist discusses how recurrent Clostridioides difficile infections are frequently associated with complex comorbidities including inflammatory conditions, immunocompromise, gastrointestinal disorders, and metabolic diseases. Management requires a nuanced, multidisciplinary approach focusing on tailored antibiotic strategies, immunomodulation, comprehensive diagnostics, and personalized treatment plans.

EP: 1.The Role of Testing for C Difficile in Clinical Practice

EP: 2.Utilizing Antibiotics in Treatment of C Difficile

EP: 3.Examining FMT for Patients With Recurrent C Difficile infections

EP: 4.Exploring Rebyota for Recurrent C Difficile Infections

EP: 5.Key Data Supporting the Use of Rebyota in Patients With Recurrent C Difficile Infections

EP: 6.Vowst as a Potential Option for Patients With Recurrent C Difficile Infections

EP: 7.Management of Recurrent C Difficile Infections in the Future

EP: 8.Key Background Information on Recurrent C. Difficile Infections

EP: 9.Importance of Early Detection of Recurrent C Difficile Infections

EP: 10.Impact of Recurrent C Difficile Infection on Costs and Patient Quality of Life

EP: 11.Diagnosis of Recurrent C Difficile Infections

Now Viewing

EP: 12.Common Comorbidities Associated With Recurrent C Difficile Infections

EP: 13.Unmet Needs With Recurrent C Difficile Infections

Video content above is prompted by the following:

What are the common comorbidities seen with recurrent C difficile infections and how can they alter the treatment of the patient?

Related Videos

Related Content

Advertisement

May 8th 2025

Uncomplicated UTIs Tied to Greater Hospitalization Risk, Higher Health Care Costs

Brooke McCormick

A study reveals higher health care costs and resource use for uncomplicated urinary tract infections (uUTIs), emphasizing the need for improved patient management strategies.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

May 6th 2025

High Soluble Klotho Levels Linked to Lower CKD Prevalence in Adults With Diabetes, Hypertension

Giuliana Grossi

New research reveals how serum soluble Klotho levels relate to chronic kidney disease risk (CKD) in patients with diabetes and hypertension.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

May 6th 2025

Longitudinal, Relationship-Based Case Management: A Prospective Cohort Trial

Patrick Runnels, MD, MBA Ryan Muskin, MA Mark Votruba, PhD Peter J. Pronovost, MD, PhD Afua Ansah, BA James Penman, LPCC

A longitudinal, relationship-based case management approach significantly reduced health care costs and improved quality of life for Medicaid enrollees with complex needs over 1 year.

May 5th 2025

Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR

Mary Caffrey

KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, as highlighted at the 2025 meeting of the American Association for Cancer Research (AACR).

Related Content

Advertisement

May 8th 2025

Uncomplicated UTIs Tied to Greater Hospitalization Risk, Higher Health Care Costs

Brooke McCormick

A study reveals higher health care costs and resource use for uncomplicated urinary tract infections (uUTIs), emphasizing the need for improved patient management strategies.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

May 6th 2025

High Soluble Klotho Levels Linked to Lower CKD Prevalence in Adults With Diabetes, Hypertension

Giuliana Grossi

New research reveals how serum soluble Klotho levels relate to chronic kidney disease risk (CKD) in patients with diabetes and hypertension.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

May 6th 2025

Longitudinal, Relationship-Based Case Management: A Prospective Cohort Trial

Patrick Runnels, MD, MBA Ryan Muskin, MA Mark Votruba, PhD Peter J. Pronovost, MD, PhD Afua Ansah, BA James Penman, LPCC

A longitudinal, relationship-based case management approach significantly reduced health care costs and improved quality of life for Medicaid enrollees with complex needs over 1 year.

May 5th 2025

Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR

Mary Caffrey

KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, as highlighted at the 2025 meeting of the American Association for Cancer Research (AACR).